Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17.3M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
10.9M
-
Shares change
-
-1.29M
-
Total reported value, excl. options
-
$34.2M
-
Value change
-
-$5.62M
-
Put/Call ratio
-
2.1
-
Number of buys
-
29
-
Number of sells
-
-58
-
Price
-
$3.14
Significant Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q2 2024
110 filings reported holding MURA - Mural Oncology plc - Ordinary shares, nominal value $0.01 per share as of Q2 2024.
Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.9M shares
of 17.3M outstanding shares and own 63.15% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.69M shares), Solas Capital Management, LLC (1.27M shares), VANGUARD GROUP INC (836K shares), WESTFIELD CAPITAL MANAGEMENT CO LP (743K shares), Alta Fundamental Advisers LLC (720K shares), Newtyn Management, LLC (570K shares), Verition Fund Management LLC (511K shares), Prosight Management, LP (475K shares), RBF Capital, LLC (388K shares), and BlackRock Inc. (343K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.